Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: 6608 POSTER Bax and p53 as Outcome Predictive in Metastatic Gastric Cancer (MGC) Patients Treated With First-Line COI (Capecitabine, Oxaliplatin, and Irinotecan) Regimen, European Journal of Cancer, September 2011, Elsevier,
DOI: 10.1016/s0959-8049(11)71919-0.
You can read the full text:
Contributors
The following have contributed to this page
